Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MMED

MiniMed Group Inc

Apr 30 • 11:39AM ET

12.42

+0.40 3.31 %

Healthcare • Health Information Services • USA • Mid • NASD

Apr 28, 9:40 AMHealth Canada licenses MiniMed 780G software adding Simplera Sync sensor support, Fiasp compatibility and adult Type 2 diabetes indication

Held by: FPX ONEQ MMID

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	90.05%	Shs Outstand	280.82M	Perf Week	-8.89%
Market Cap	3.49B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	27.93M	Perf Month	-16.77%
Enterprise Value	3.54B	PEG	-	EPS next Q	-	Inst Own	0.01%	Short Float	10.23%	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	0.08%	Short Ratio	2.39	Perf Half Y	-
Sales	-	P/B	1.01	EPS next Y	-	ROA	-	Short Interest	2.86M	Perf YTD	-32.84%
Book/sh	12.33	P/C	348.71	EPS next 5Y	-	ROE	-	52W High	20.48 -39.37%	Perf Year	-
Cash/sh	0.04	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	12.01 3.39%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.38% 6.96%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	0.94	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.01	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	34.19	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	1.59	EPS Q/Q	-	SMA20	-8.80%	Beta	-	Target Price	22.45
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	-17.02%	Rel Volume	0.51	Prev Close	12.02
Employees	-	LT Debt/Eq	0.01	Earnings	-	SMA200	-17.02%	Avg Volume	1.20M	Price	12.42
IPO	Mar 06, 2026	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	222,445	Change	3.31%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-31-26	Initiated	William Blair	Outperform
Mar-31-26	Initiated	Wells Fargo	Overweight	$26
Mar-31-26	Initiated	Piper Sandler	Neutral	$16
Mar-31-26	Initiated	Morgan Stanley	Overweight	$19
Mar-31-26	Initiated	Mizuho	Outperform	$21
Mar-31-26	Initiated	Goldman	Buy	$24
Mar-31-26	Initiated	Evercore ISI	Outperform	$20
Mar-31-26	Initiated	Deutsche Bank	Buy	$20
Mar-31-26	Initiated	Citigroup	Buy	$23
Mar-31-26	Initiated	BTIG Research	Buy	$25
Mar-31-26	Initiated	BofA Securities	Buy	$27

Show Previous Ratings

Apr-28-26 09:05AM	MiniMed announces Health Canada License for Simplera Sync Sensor, Type 2 Diabetes Indication with MiniMed 780G System (GlobeNewswire)
Apr-13-26 04:01PM	MiniMed to announce financial results for its fourth quarter and full fiscal year 2026 (PR Newswire) +5.70%
Mar-31-26 03:09PM	MiniMed initiated with Buy rating by Bank of America on pipeline-driven growth outlook (Proactive)
09:32AM	Western Digital upgraded, PayPal initiated: Wall Street's top analyst calls (The Fly)
Mar-18-26 09:06AM	MiniMed Announces FDA Clearance of MiniMed Flex, the Company's Smallest Insulin Pump Featuring Its First Smartphone-Controlled Design (PR Newswire)
04:59PM	Loading…
Mar-09-26 04:59PM	MiniMed announces closing of Initial Public Offering (PR Newswire)
Mar-06-26 09:00AM	MiniMed to begin trading on Nasdaq Global Select Market (PR Newswire)
09:00AM	MiniMed begins trading on Nasdaq Global Select Market (PR Newswire)

MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets, software platforms, and related accessories that help patients and healthcare providers effectively monitor and control blood glucose levels. The company was founded by Alfred E. Mann in 1983 and is headquartered in Northridge, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MMED

MiniMed Group Inc

Upgrade your Finviz experience